Year |
Citation |
Score |
2024 |
Park S, Silva E, Singhal A, Kelly MR, Licon K, Panagiotou I, Fogg C, Fong S, Lee JJY, Zhao X, Bachelder R, Parker BA, Yeung KT, Ideker T. A deep learning model of tumor cell architecture elucidates response and resistance to CDK4/6 inhibitors. Nature Cancer. PMID 38443662 DOI: 10.1038/s43018-024-00740-1 |
0.32 |
|
2024 |
Sinha S, Farfel A, Luker KE, Parker BA, Yeung KT, Luker GD, Ghosh P. Growth signaling autonomy in circulating tumor cells aids metastatic seeding. Pnas Nexus. 3: pgae014. PMID 38312224 DOI: 10.1093/pnasnexus/pgae014 |
0.36 |
|
2023 |
Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, Allison KH, Anderson B, Burstein HJ, Chew H, Dang C, Elias AD, Giordano SH, Goetz MP, Goldstein LJ, ... ... Yeung K, et al. NCCN GuidelinesĀ® Insights: Breast Cancer, Version 4.2023. Journal of the National Comprehensive Cancer Network : Jnccn. 21: 594-608. PMID 37308117 DOI: 10.6004/jnccn.2023.0031 |
0.484 |
|
2021 |
Douglas SR, Yeung KT, Yang J, Blair SL, Cohen O, Eliceiri BP. Identification of CD105+ Extracellular Vesicles as a Candidate Biomarker for Metastatic Breast Cancer. The Journal of Surgical Research. 268: 168-173. PMID 34314883 DOI: 10.1016/j.jss.2021.06.050 |
0.478 |
|
2018 |
Nakazawa Y, Taniyama Y, Sanada F, Morishita R, Nakamori S, Morimoto K, Yeung KT, Yang J. Periostin blockade overcomes chemoresistance via restricting the expansion of mesenchymal tumor subpopulations in breast cancer. Scientific Reports. 8: 4013. PMID 29507310 DOI: 10.1038/S41598-018-22340-7 |
0.576 |
|
2017 |
Yeung KT, More S, Woodward B, Velculescu V, Husain H. Circulating Tumor DNA for Mutation Detection and Identification of Mechanisms of Resistance in Non-Small Cell Lung Cancer. Molecular Diagnosis & Therapy. PMID 28337711 DOI: 10.1007/S40291-017-0260-5 |
0.378 |
|
2017 |
Yeung KT, Yang J. Epithelial-mesenchymal transition in tumor metastasis. Molecular Oncology. 11: 28-39. PMID 28085222 DOI: 10.1002/1878-0261.12017 |
0.449 |
|
2017 |
Jung H, Yeung KT, Lee T, Tsai JH, Yang J. Abstract 3052: Defining the role of EMT in breast cancer dormancy and metastasisin vivo Cancer Research. 77: 3052-3052. DOI: 10.1158/1538-7445.Am2017-3052 |
0.539 |
|
2014 |
Das S, Yeung KT, Mahajan MA, Samuels HH. Fas Activated Serine-Threonine Kinase Domains 2 (FASTKD2) mediates apoptosis of breast and prostate cancer cells through its novel FAST2 domain. Bmc Cancer. 14: 852. PMID 25409762 DOI: 10.1186/1471-2407-14-852 |
0.612 |
|
2011 |
Yeung KT, Das S, Zhang J, Lomniczi A, Ojeda SR, Xu CF, Neubert TA, Samuels HH. A novel transcription complex that selectively modulates apoptosis of breast cancer cells through regulation of FASTKD2. Molecular and Cellular Biology. 31: 2287-98. PMID 21444724 DOI: 10.1128/Mcb.01381-10 |
0.629 |
|
2009 |
Tinnikov AA, Yeung KT, Das S, Samuels HH. Identification of a novel pathway that selectively modulates apoptosis of breast cancer cells. Cancer Research. 69: 1375-82. PMID 19190336 DOI: 10.1158/0008-5472.Can-08-2896 |
0.63 |
|
Show low-probability matches. |